Dr. Kevin Palka, M.D.
Claim this profileWashington University School of Medicine
Studies Squamous Cell Carcinoma
Studies Thyroid Cancer
10 reported clinical trials
20 drugs studied
Area of expertise
1Squamous Cell Carcinoma
p16 positive
Stage IV
p16 negative
2Thyroid Cancer
p16 positive
Stage IV
p16 negative
Affiliated Hospitals
Clinical Trials Kevin Palka, M.D. is currently running
APL-101 + Osimertinib
for Non-Small Cell Lung Cancer
In this study, patients with metastatic non-small cell lung cancer that is EGFR-mutated, who have received at least 8 and not more than 12 weeks of treatment with osimertinib without demonstrating disease progression, will receive APL-101 in combination with osimertinib until progression. Dosing of APL-101 will be escalated until the maximum tolerated dose is determined, at which point 10 additional patients will be enrolled at that dose in the expansion cohort.
Recruiting1 award Phase 1 & 28 criteria
CUE-101
for Throat Cancer
This trial tests a new treatment called CUE-101 to see if it is safe and effective for patients with a specific type of throat cancer. The treatment aims to boost the immune system before standard cancer therapy. Patients are newly diagnosed and have not yet received any other treatments.
Recruiting1 award Phase 2
More about Kevin Palka, M.D.
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kevin Palka, M.D. has experience with
- Cetuximab
- Palbociclib
- Pembrolizumab
- Mitomycin-C
- Pegfilgrastim
- Cisplatin
Breakdown of trials Kevin Palka, M.D. has run
Squamous Cell Carcinoma
Thyroid Cancer
Head and Neck Squamous Cell Carcinoma
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin Palka, M.D. specialize in?
Kevin Palka, M.D. focuses on Squamous Cell Carcinoma and Thyroid Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved p16 positive patients, or patients who are Stage IV.
Is Kevin Palka, M.D. currently recruiting for clinical trials?
Yes, Kevin Palka, M.D. is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Kevin Palka, M.D. has studied deeply?
Yes, Kevin Palka, M.D. has studied treatments such as Cetuximab, Palbociclib, Pembrolizumab.
What is the best way to schedule an appointment with Kevin Palka, M.D.?
Apply for one of the trials that Kevin Palka, M.D. is conducting.
What is the office address of Kevin Palka, M.D.?
The office of Kevin Palka, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.